Hequn Q. Huang

81 Meishan Road
Hefei, 230032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Topical 1.5% ruxolitinib cream for facial refractory segmental vitiligo: A retrospective single-center study.

Topical 1.5% ruxolitinib cream for facial refractory segmental vitiligo: A retrospective single-center study.

Journal: JAAD international

Published: November 17, 2025

Clinical efficacy and safety analysis of 1.5% ruxolitinib cream in the treatment of facial vitiligo in adolescents: A retrospective study of 74 cases.

Clinical efficacy and safety analysis of 1.5% ruxolitinib cream in the treatment of facial vitiligo in adolescents: A retrospective study of 74 cases.

Journal: Journal of the American Academy of Dermatology

Published: November 15, 2025

Targeted synergy for vitiligo in refractory areas: A real-world study of ruxolitinib cream combined with 308-nm excimer lamp.

Targeted synergy for vitiligo in refractory areas: A real-world study of ruxolitinib cream combined with 308-nm excimer lamp.

Journal: Journal of the American Academy of Dermatology

Published: November 05, 2025

Beyond depigmentation: A cross-sectional study of 5227 Chinese patients with vitiligo.

Beyond depigmentation: A cross-sectional study of 5227 Chinese patients with vitiligo.

Journal: The Journal of investigative dermatology

Published: August 19, 2025

Efficacy of ruxolitinib cream at different body sites in Chinese patients with nonsegmental vitiligo.

Efficacy of ruxolitinib cream at different body sites in Chinese patients with nonsegmental vitiligo.

Journal: Journal of the American Academy of Dermatology

Published: May 21, 2025

Effectiveness and safety of ruxolitinib cream in Chinese patients with nonsegmental vitiligo.

Effectiveness and safety of ruxolitinib cream in Chinese patients with nonsegmental vitiligo.

Journal: Journal of the American Academy of Dermatology

Published: October 29, 2024

Efficacy and safety of secukinumab in Chinese patients with psoriasis: Update of six-year real-world data and a meta-analysis.

Efficacy and safety of secukinumab in Chinese patients with psoriasis: Update of six-year real-world data and a meta-analysis.

Journal: Chinese medical journal

Published: October 24, 2024

Intelligent Diagnosis of Hypopigmented Dermatoses and Intelligent Evaluation of Vitiligo Severity on the Basis of Deep Learning.

Intelligent Diagnosis of Hypopigmented Dermatoses and Intelligent Evaluation of Vitiligo Severity on the Basis of Deep Learning.

Journal: Dermatology and therapy

Published: August 01, 2024

A novel splice-site variant of the LAMB3 gene is associated with junctional epidermolysis bullosa

A novel splice-site variant of the LAMB3 gene is associated with junctional epidermolysis bullosa

Journal: European journal of dermatology : EJD

Published: December 05, 2022

The role of TNF-α/TNFR1 inhibiting autophagy of M1-type Kupffer cells in liver injury in trichloroethylene-sensitized mice

The role of TNF-α/TNFR1 inhibiting autophagy of M1-type Kupffer cells in liver injury in trichloroethylene-sensitized mice

Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases

Published: June 09, 2022

The role of ROS/TXNIP/NLRP3 pathway in the skin injury of trichloroethylene sensitized mice

The role of ROS/TXNIP/NLRP3 pathway in the skin injury of trichloroethylene sensitized mice

Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases

Published: May 11, 2022

A novel variant in the GJB6 gene in a large Chinese family with a unique phenotype of Clouston syndrome.

A novel variant in the GJB6 gene in a large Chinese family with a unique phenotype of Clouston syndrome.

Journal: Frontiers of medicine

Published: November 10, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026